Klaus Fellermann
Impact in
- Microbiology top 0.1%
- Antimicrobial Peptides and Activities
- Genetics top 0.5%
- Inflammatory Bowel Disease
Papers in
- Microbiology 24
- Antimicrobial Peptides and Activities 24
- Genetics 49
- Inflammatory Bowel Disease 46
- Co-authors
- Eduard F. StangeJan WehkampKlaus HerrlingerMatthias SchwabCharles BevinsMiriam SchleeSabine NudingJürgen Harder
- Journals
- Alimentary Pharmacology & Therapeutics (9 papers)Inflammatory Bowel Diseases (8 papers)Journal of Crohn s and Colitis (7 papers)European Journal of Gastroenterology & Hepatology (6 papers)Gastroenterology (5 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Klaus Fellermann
100 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Microbiology 1.6k
- Genetics 2.6k
- Immunology 2.0k
- Emergency Medical Services 488
- Gastroenterology 359
Countries citing papers authored by Klaus Fellermann
This map shows the geographic impact of Klaus Fellermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Fellermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Fellermann more than expected).
Fields of papers citing papers by Klaus Fellermann
This network shows the impact of papers produced by Klaus Fellermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Fellermann. The network helps show where Klaus Fellermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus Fellermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 4 | |
| 2 | 2017 | 3 | |
| 3 | 2016 | 54 | |
| 4 | 2016 | 4 | |
| 5 | 2014 | 22 | |
| 6 | 2014 | 0 | |
| 7 | 2014 | 18 | |
| 8 | 2011 | 39 | |
| 9 | Keep in Mind: Cyclophosphamide as Effective and Safe Therapeutic Option in Severely Active Crohn's Disease | 2010 | 5 |
| 10 | 2010 | 52 | |
| 11 | 2009 | 221 | |
| 12 | 2007 | 220 | |
| 13 | Reduced Paneth cell α-defensins in ileal Crohn's disease Hit paper breakdown → | 2005 | 749 |
| 14 | 2005 | 115 | |
| 15 | NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression Hit paper breakdown → | 2004 | 618 |
| 16 | 2003 | 51 | |
| 17 | 2001 | 51 | |
| 18 | 1999 | 42 | |
| 19 | 1999 | 65 | |
| 20 | 1998 | 25 |
About Klaus Fellermann
Klaus Fellermann is a scholar working on Microbiology, Genetics, Emergency Medical Services, Immunology and Hepatology, having authored 103 papers that have together received 6.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (46 papers), Antimicrobial Peptides and Activities (24 papers), Microscopic Colitis (22 papers), Immune Response and Inflammation (11 papers), Probiotics and Fermented Foods (11 papers), Pancreatitis Pathology and Treatment (10 papers), Pediatric health and respiratory diseases (9 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). The work is most often cited by research in Microbiology (1.6k citations), Genetics (2.6k citations), Immunology (2.0k citations), Emergency Medical Services (488 citations) and Gastroenterology (359 citations). Klaus Fellermann has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Eduard F. Stange, Jan Wehkamp, Klaus Herrlinger, Matthias Schwab, Charles Bevins, Miriam Schlee, Sabine Nuding, Jürgen Harder, Michael Weichenthal and Elke Schaeffeler. Their work appears in journals such as Alimentary Pharmacology & Therapeutics, Inflammatory Bowel Diseases, Journal of Crohn s and Colitis, European Journal of Gastroenterology & Hepatology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.